deferoxamine has been researched along with sincalide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cao, Y; Tang, J; Wang, R; Zhang, H | 1 |
1 review(s) available for deferoxamine and sincalide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for deferoxamine and sincalide
| Article | Year |
|---|---|
Ferulic Acid Mitigates Growth and Invasion of Esophageal Squamous Cell Carcinoma through Inducing Ferroptotic Cell Death.
Topics: Caspase 3; Deferoxamine; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Ferroptosis; Humans; Iron; Proto-Oncogene Proteins c-sis; Reactive Oxygen Species; Sincalide; Superoxide Dismutase | 2022 |